Skip to content

Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03986736
Enrollment
150
Registered
2019-06-14
Start date
2019-06-15
Completion date
2022-12-31
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Trauma, Rhabdomyolysis, Tissue Injury

Keywords

rhabdomyolysis, tissue injury, alarmins, major trauma, acute kidney injury

Brief summary

Major trauma is associated with a release of alarmins (DAMPs - damage-associated molecular patterns) from the injured tissues. This process results in the activation of the immune system, which is one of the main mechanisms participating in the development of organ dysfunctions in patients with major trauma.

Detailed description

Major trauma is associated with a release of alarmins (DAMPs - damage-associated molecular patterns) from the injured tissues. This process results in the activation of the immune system, which is one of the main mechanisms participating in the development of organ dysfunctions in patients with major trauma. Limited literary sources describe a correlation between the mitochondrial DNA (mDNA) and the value of plasma creatine kinase (sCK) (which is released from the injured muscles), which suggests a possible correlation between the number of released alarmins and the degree of rhabdomyolysis (damage of striated muscles). Rhabdomyolysis is further - due to the direct nephrotoxicity of myoglobin (sMb) released from the injured muscles - a significant factor participating in the development of acute renal failure in patients with serious injuries. Considering the fact that the serious injury need not include a vast damage of the muscle mass (especially in traumas with a minimal impairment of extremities), the correlation between the DAMPs and sCK/sMb values need not be constant in relation to the extent and localization of the injury defined with the AIS (Abbreviated Injury Scale) and ISS (Injury Severity Scale) scales. The DAMPs released from injured tissues immediately after trauma include HMGB-1 (high mobility group box 1); a correlation has been observed between the early post-injury levels of HMGB-1 and unfavorable outcome (defined with development of organ dysfunctions and increased mortality). Considering the fact that the DAMPs examination (including HMGB-1) are routinely available, and are also rather expensive, they are not a standard part of examinations performed in patients with serious trauma. Determination of correlation between HMGB-1 and the routinely available examinations of sCK and sMb would make the use of sCK and sMb examinations as direct indicators of mechanical tissue damage. Furthermore, this data has a significant descriptive impact in case of direct inclusion of sCK and sMb into predictive scoring systems, which currently do not contain relevant physiological parameters correlating with the extent of the injury. In the second part of the study, the authors will concentrate upon evaluation of correlation of HMGB-1, serum creatine kinase and serum myoglobin in relation to the development of acute kidney injury (AKI), and in relation to the values of AKI markers, specifically NGAL (neutrophil-gelatinase associated lipocalin). The currently used AKI criteria are based upon relatively imprecise and late parameters (urine output, level of serum creatinine), and that is why AKI is identified in the clinical practice only in the stage of advanced and irreversible morphological and functional changes of kidneys. The aims of the study are the following: * To verify the correlation between the levels of circulating alarmins (HMGB-1) and the levels of sCK and sMb * To identify the correlation between the levels of circulating alarmins and localization of the injury (according to AIS and ISS scoring systems) * Mutual comparison of predictive levels of sCK and sMb in relation to the development of post-injury kidney failure * Mutual comparison of predictive levels of sCK and sMb in relation to the serum and urine levels of AKI biomarkers * Comparison of predictive levels of serum and urine NGAL in relation to the development of post-injury AKI

Interventions

DIAGNOSTIC_TESTLaboratory analysis - upon admission

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: HMGB-1, sCK, sMb, serum NGAL, and urine NGAL

DIAGNOSTIC_TESTLaboratory analysis - 24 hours after injury

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: sCK, sMb, serum NGAL, and urine NGAL

Sponsors

University Hospital Ostrava
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of polytrauma * ISS ≥ 16

Exclusion criteria

* history of a significant kidney impairment * pregnancy * injuries incompatible with life, with anticipated survival \< 24 hours * transfer to palliative care within the first 24 hours after injury * death within the first 24 hours after injury

Design outcomes

Primary

MeasureTime frameDescription
Correlation between sCK/sMb levels in relation to the degree and localisation of injury24 hoursCorrelation between sCK/sMb levels in relation to the degree and localisation of injury will be assessed according to the AIS and ISS scoring scales.
Mutual comparison of predictive levels of sCK/sMb in relation to serum and urine AKI biomarkers neutropil-gelatinase associated lipocalin (NGAL)8 daysMutual comparison of predictive levels of sCK/sMb in relation to serum and urine AKI biomarker NGAL will be assessed.
Comparison of predictive levels of serum and urine NGAL in relation to post-injury acute kidney injury development defined by KDIGO criteria.8 daysComparison of predictive levels of serum and urine NGAL in relation to post-injury acute kidney injury (defined by KDIGO criteria based both on serum creatine level investigated daily and urine output collected hourly from time of admission to Day 8 after injury) development will be assessed.
Correlation between HMGB-1 and sCK/sMb levels24 hoursCorrelation between HMGB-1 and sCK/sMb levels will be assessed.
Mutual comparison of predictive levels of sCK/sMb in relation to post-injury acute kidney injury defined by KDIGO criteria8 daysMutual comparison of predictive levels of sCK/sMb in relation to development of post-injury acute kidney injury (defined by KDIGO criteria based both on serum creatine level investigated daily and urine output collected hourly from time of admission to Day 8 after injury) development will be assessed.

Secondary

MeasureTime frameDescription
Reliability of HMGB-1 and other DAMPS in predicting organ dysfunction in intensive care unit patients8 daysThe correlation between HMGB-1 and other DAMPS levels and the occurrence of organ dysfunction will be observed in intensive care unit patients
Reliability of HMGB-1 in predicting major blood loss in patients with severe trauma8 daysThe correlation between the HMGB-1 levels and the blood loss (in ml) will be observed in patients with severe trauma

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026